Maven Securities’s Disc Medicine IRON Stock Holding History

Maven Securities’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-61	Closed	-$25K	–	1183
2021 Q1	$25K	Buy	+61	New	+$27.2K	﹤0.01%	1141

Other funds holding IRON

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Maven Securities's IRON Position: Q2 2021 in Review

Maven Securities sold out of Disc Medicine (IRON) in Q2 2021, closing a stake of 61 shares — an estimated $25K sold.

Maven Securities first reported a position in IRON in Q1 2021 and held it in 1 quarter. The position peaked at $25K in Q1 2021. 55 funds tracked by Wall St. Rank hold IRON as of Q2 2021.

Maven Securities reported no remaining Disc Medicine position as of Q2 2021 after selling out during the quarter.
Maven Securities sold 61 Disc Medicine shares in Q2 2021, an estimated $25K.
Maven Securities first reported a position in Disc Medicine in Q1 2021 and held it in 1 quarter.
Maven Securities's Disc Medicine position peaked at $25K in Q1 2021.
55 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2021.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.